Cargando…

P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH

Detalles Bibliográficos
Autores principales: Griffin, Morag, Humphreys, Jane, Philpot, Edward, Jason Cummings, W., Pullman, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430637/
http://dx.doi.org/10.1097/01.HS9.0000970052.45858.28
_version_ 1785091014168412160
author Griffin, Morag
Humphreys, Jane
Philpot, Edward
Jason Cummings, W.
Pullman, William
author_facet Griffin, Morag
Humphreys, Jane
Philpot, Edward
Jason Cummings, W.
Pullman, William
author_sort Griffin, Morag
collection PubMed
description
format Online
Article
Text
id pubmed-10430637
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104306372023-08-17 P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH Griffin, Morag Humphreys, Jane Philpot, Edward Jason Cummings, W. Pullman, William Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430637/ http://dx.doi.org/10.1097/01.HS9.0000970052.45858.28 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Griffin, Morag
Humphreys, Jane
Philpot, Edward
Jason Cummings, W.
Pullman, William
P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH
title P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH
title_full P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH
title_fullStr P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH
title_full_unstemmed P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH
title_short P787: ALTERNATIVE PATHWAY MASP-3 INHIBITOR OMS906: RESULTS FROM A FIRST-IN-MAN PHASE 1 STUDY IN HEALTHY SUBJECTS AND STUDY DESIGN OF TWO ONGOING CLINICAL TRIALS IN PATIENTS WITH PNH
title_sort p787: alternative pathway masp-3 inhibitor oms906: results from a first-in-man phase 1 study in healthy subjects and study design of two ongoing clinical trials in patients with pnh
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430637/
http://dx.doi.org/10.1097/01.HS9.0000970052.45858.28
work_keys_str_mv AT griffinmorag p787alternativepathwaymasp3inhibitoroms906resultsfromafirstinmanphase1studyinhealthysubjectsandstudydesignoftwoongoingclinicaltrialsinpatientswithpnh
AT humphreysjane p787alternativepathwaymasp3inhibitoroms906resultsfromafirstinmanphase1studyinhealthysubjectsandstudydesignoftwoongoingclinicaltrialsinpatientswithpnh
AT philpotedward p787alternativepathwaymasp3inhibitoroms906resultsfromafirstinmanphase1studyinhealthysubjectsandstudydesignoftwoongoingclinicaltrialsinpatientswithpnh
AT jasoncummingsw p787alternativepathwaymasp3inhibitoroms906resultsfromafirstinmanphase1studyinhealthysubjectsandstudydesignoftwoongoingclinicaltrialsinpatientswithpnh
AT pullmanwilliam p787alternativepathwaymasp3inhibitoroms906resultsfromafirstinmanphase1studyinhealthysubjectsandstudydesignoftwoongoingclinicaltrialsinpatientswithpnh